| Logo | Name | Σ |
|---|---|---|
 | MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: Pharmaceutical | 2158 |
 | Medtronic A global healthcare technology leader — boldly attacking the most challenging health problems facing humanity with innovations that transform lives. Sectors: Pharmaceutical | 1048 |
 | Johnson & Johnson At Johnson & Johnson, we believe health is everything. As a focused healthcare company, with expertise in Innovative Medicine and MedTech, we’re empowered to tackle the world’s toughest health challenges, innovate through science and technology, and transform patient care. All of this is possible because of our people. We’re passionate innovators who put people first, and through our purpose-driven culture and talented workforce, we are stronger than ever. Learn more at https://www.jnj.com. Community Guidelines: http://www.jnj.com/social-media-community-guidelines Health Care, Medical Devices & Diagnostics, and Pharmaceuticals Sectors: Pharmaceutical | 4633 |
 | Sofinnova Partners Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential … | 418 |
 | Pierre Fabre Laboratories New ways to care Laboratoires Pierre Fabre held by the Pierre Fabre Foundation, is a worldwide company with a unique positioning : the alliance of pharmaceutical and dermocosmetics expertise. This makes Pierre Fabre Group : 💊 A pharmaceutical group with a strong positioning : medical and natural 🥈 The second largest dermo-cosmetics laboratory in the world 🥈 The second largest private French pharmaceutical group 🥇 The market leader in France for products sold over the counter in pharmacies. Our portfolio includes several medical franchises and international brands including ; Pharmaceutical Care Pierre Fabre Oncologie Pierre Fabre Dermatologie Naturactive Eau Thermale … Sectors: Pharmaceutical | 818 |
 | Linkera Support for fundraising and transfer/acquisition - Startups and VSE/SMEs valuation - UGAP rating Linkera is the essential solution dedicated to the optimization of acquisition and business transfer. The platform allows you to connect owners of potential businesses and buyers. Each month, it presents companies and assets worth millions of euros to nearly 2,000 users. Innovation, entrepreneurship, rating, financial advice & amp; Extra-financial, investment, algorithm, data, ugap, valuation, fundraising, sales, acquisitions, financing, startups, TPE, and SMEs Sectors: Consulting | 1191 |
 | HTGF | High-Tech Gründerfonds We believe in tech. We invest in people. HTGF is one of the leading and most active early-stage investors in Germany and Europe, financing start-ups in the fields of Deep Tech, Industrial Tech, Climate Tech, Digital Tech, Life Sciences and Chemistry. With its experienced investment team, HTGF supports start-ups in all phases of their development into international market leaders. HTGF invests in pre-seed and seed phases and can participate significantly in later-stage financing rounds. Across its funds, HTGF has over 2 billion euros under management. Since its inception in 2005, HTGF has financed more than 770 start-ups and successfully sold … | 950 |
 | Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: Pharmaceutical | 1706 |
 | Teva Pharmaceuticals At Teva, we're proud to be a different kind of global pharmaceutical leader, one that operates across the full spectrum of innovation to reliably deliver medicines to patients worldwide. For over 120 years, our commitment to bettering health has never wavered. Every day, we challenge ourselves to push the boundaries of science, discover life-changing treatments, and deliver quality medicines. If patients have a need, we’re already working to address it. Because here, we are all in for better health. Learn more at www.tevapharm.com. Please note that adverse effects for any of our products should be reported to: Safety.AE@teva.co.il Product-specific questions … Sectors: Pharmaceutical | 1881 |
 | Bpifrance Bpifrance account, the public investment bank. Bpifrance, public investment bank, supports businesses, from priming to stock market quotes, from credit to equity. A privileged interlocutor, Bpifrance offers in each region financing or investment solutions adapted to each stage of business life. Bank partner of entrepreneurs, Bpifrance supports them sustainably to support their growth and competitiveness. The teams are at the heart of the regions, throughout the territory, through more than 50 regional locations. Financing of SMEs, business creation, international development, investment, creation/transmission, innovation, support, acceleration, and export guarantee Sectors: Bank | 13079 |
 | Oxford Science Enterprises We find, fund and build transformational businesses via our unique partnership with the University of Oxford Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to find, fund and build transformational businesses across specialist areas of life sciences, health tech, AI, new compute, climate tech and agtech. Via our unique partnership with the University of Oxford, the world's #1 research university, we turn the world's most advanced science and technology into companies tackling the world's toughest challenges. In nine years, we have invested £0.7 billion in over 120 ambitious companies built on Oxford science. A key … Sectors: Startup accelerator & VC | 291 |
 | Investissement Québec L'univers fascinant de l'entrepreneuriat et des gens dévoués qui contribuent au développement économique du Québec Investissement Québec is the go-to partner for foreign and Québec-based businesses seeking to make a go of it in the province. You can count on our experienced team, resources and financial solutions to assist you on the road to success. Working out of 17 offices across Québec and 12 more around the world, our experts have a thorough understanding of your business environment and the unique challenges you face. That is our defining strength and the reason why so many businesses put their trust and … Sectors: Finance | 595 |
 | Gilead Sciences Creating Possible At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines Sectors: Biotechnology Pharmaceutical | 831 |
 | Moderna Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using … Sectors: Biotechnology Pharmaceutical | 725 |
 | AstraZeneca We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio Pharmaceutical, Biopharmaceutical, Innovation, Research and development, and Global business Sectors: Pharmaceutical | 3923 |
 | Alexion Pharmaceuticals, Inc. Transforming Lives, Every Day. Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, supportive technologies, and healthcare services. Dedicated to continuing its mission as part of AstraZeneca, Alexion recognizes that patients and caregivers are people first, and by understanding their experiences, Alexion is better able to serve their unique needs. Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex … Sectors: Biotechnology Pharmaceutical | 274 |
 | AbbVie AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html. Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care Sectors: Pharmaceutical | 982 |
 | 500 Global Venture Capital firm on a mission to uplift people and economies worldwide through entrepreneurship. 500 Global is a venture capital firm with over $2.7B in Assets Under Management that invests early in founders building fast-growing technology companies. We focus on markets where technology, innovation, and capital can unlock long-term value and drive economic growth. 500 Global has backed over 5,000 founders representing more than 2,600 companies operating in 80 countries. Our portfolio includes 51 companies valued at over $1 billion and 140 companies valued at over $100 million. Our 140+ plus team members are located in more than 15 countries … Sectors: Startup accelerator & VC | 2963 |
 | Sequoia Capital Sequoia helps daring founders build legendary companies from idea to IPO and beyond. We aim to be the first true believers in tomorrow’s most valuable and enduring businesses. We partner with a few outliers each year and go all-in, providing them with the hands-on help required at every stage of the company building journey. Our expertise comes from 50 years of working with legendary founders like Steve Jobs, Larry Page, Jan Koum, Adi Tatarko, Brian Chesky, Jensen Huang, Anne Wojcicki, Eric Yuan, Patrick Collison, Julia Hartz, and Sebastian Siemiatkowski. In aggregate, Sequoia-backed companies account for more than 25% of NASDAQ's … Sectors: Startup accelerator & VC | 2454 |
 | Nasdaq At Nasdaq, our purpose is to advance economic progress for all. At Nasdaq, our purpose is to advance economic progress for all. We power stronger economies, create more equitable opportunities, and contribute to a more sustainable world to help our communities, clients, employees, and people of all backgrounds reach their full potential. Meet the #NasdaqFam and learn about our purpose, culture and careers here: https://www.nasdaq.com/about/careers Technology Solutions, Financial Markets, Global Trading, Equities, Market Technology, Market Services, Fixed Income, Derivatives, Corporate Solutions, Global Index Services, Listing Services, and Nasdaq MarketSite Sectors: Finance | 6781 |